My response: I did not contribute as a Cancer researcher but as an experienced computer science professional with Basic Medical System education. I was never a cancer researcher.
I was volunteered to be on glasshouse cancer to contribute to its treatment in 2004. In 2004's meeting, I was already told its research technology is the laser.
In 2014, my treatment of this glass house cancer started on Christmas. The technology used, I checked online, is High Pressure Liquidated Laser (HPLL).
The laser can be liquidated and transmitted remotely is the base of this treatment technology. I enjoyed this wonderful technology of remote micro-surgery, and it inspired me of cancer treatment because I referred my own health situation as glass house cancer.
This HPLL can be understood as a remote computerized micro-surgery. It is the combination of computerized micro-surgery technology with laser surgery technology. The great part is, of course, the benefit of the both which resulted in no-open-surgery with accuracy can be reached to cells level.
I did input my thoughts of using this to treat cancer that clean surgery of complete removal of original or spread locations can be achieved by this HPLL's combined advantage of laser and cell level micro-accuracy. And I do know a lot of people knew this technology also input the similar thoughts.
It is well known that cancer treatment's nightmare is its spreading issue. And I did contribute my thoughts on to use Hemodialysis (Adsorbing Carbon rod blood filtering technology) several times to remove cancer carcinogens after each surgery. I heard this using Hemodialysis is the contribution I did or combined HPLL surgery with this Hemodialysis is the contribution I did.
Other than this, I contributed on how to improve research-oriented treatment technology to clinic-usage treatment technology.
*HIV new treatment technology is similar to this.
*Spreading prevention through "several times of Hemodialysis after each surgery" is my contribution to the cancer treatment, updated on May 21st, 2018.
*The new cancer treatment technology can also be used to treat Alzheimer patient if use more strict option on local retaining, please ask manufacturing company about more information of this option. Only overnight recovery, a severely progressive Alzheimer patient can be as good as a month ago -- A five-minutes surgery can win-back one-month precious space that lost in current battle, a daily-surgery affordable technology.
----Nov. 7th, 2017
----Grammars corrected on February 16th, 2018
*I am privileged to bring ta great tidings here to tell everyone that this new technology may also be used to treat Albinism. So far I know is, the in-developing Albinism can be treated as an infection- caused cancer type, so may be OCA1, OCA 2 or OCA4. The tips I pass along are "need to appy treatment to the entire affected area( can't be partial), and pay attention to the bottom-edge to the healthy area". Cell and cell-contents need healthiest choice for all selectable, and possibly need to turn on all skin related treatment features . May be in one hour time, doctors will be able to see the healthy cells started smoothly replacing the infected area. If heard of biological treament's finger-replace tools and if applicable, applying these tools the same way can greatly improve the treatment speeds.----March 11th, 2020.
-------------
**There may have been some confusion about a cancer researcher Min Fang (方敏）, according to her resume I found online, she is graduated from the same medical school with me from same year --Shanghai Medical University, 1990. I am not this following Min Fang.
Min Fang, MD, PhD
PROFESSOR | DIRECTOR OF CYTOGENETICS, SEATTLE CANCER CARE ALLIANCE
Education and Training
Postdoctoral Fellow, Clinical Molecular Genetics and Cytogenetics, Stanford University School of Medicine, 1998-2002
Ph.D., the University of Alabama at Birmingham, 1998
M.D., Shanghai Medical University, China, 1990
http://www.pathology.washington.edu/faculty/fang
Other than this, I contributed on how to improve research-oriented treatment technology to clinic-usage treatment technology.
*HIV new treatment technology is similar to this.
*Spreading prevention through "several times of Hemodialysis after each surgery" is my contribution to the cancer treatment, updated on May 21st, 2018.
*The new cancer treatment technology can also be used to treat Alzheimer patient if use more strict option on local retaining, please ask manufacturing company about more information of this option. Only overnight recovery, a severely progressive Alzheimer patient can be as good as a month ago -- A five-minutes surgery can win-back one-month precious space that lost in current battle, a daily-surgery affordable technology.
(proudly saying: co-discover this option is my contribution, updated on October 21st, 2018).
----Nov. 7th, 2017
----Grammars corrected on February 16th, 2018
*I am privileged to bring ta great tidings here to tell everyone that this new technology may also be used to treat Albinism. So far I know is, the in-developing Albinism can be treated as an infection- caused cancer type, so may be OCA1, OCA 2 or OCA4. The tips I pass along are "need to appy treatment to the entire affected area( can't be partial), and pay attention to the bottom-edge to the healthy area". Cell and cell-contents need healthiest choice for all selectable, and possibly need to turn on all skin related treatment features . May be in one hour time, doctors will be able to see the healthy cells started smoothly replacing the infected area. If heard of biological treament's finger-replace tools and if applicable, applying these tools the same way can greatly improve the treatment speeds.----March 11th, 2020.
-------------
**There may have been some confusion about a cancer researcher Min Fang (方敏）, according to her resume I found online, she is graduated from the same medical school with me from same year --Shanghai Medical University, 1990. I am not this following Min Fang.
Min Fang, MD, PhD
PROFESSOR | DIRECTOR OF CYTOGENETICS, SEATTLE CANCER CARE ALLIANCE
Education and Training
Postdoctoral Fellow, Clinical Molecular Genetics and Cytogenetics, Stanford University School of Medicine, 1998-2002
Ph.D., the University of Alabama at Birmingham, 1998
M.D., Shanghai Medical University, China, 1990
http://www.pathology.washington.edu/faculty/fang